Response to Gefitinib/Crizotinib Combination in a Pulmonary Sarcomatoid Carcinoma Patient Harboring Concurrent EGFR Mutation and MET Amplification

loading page

Abstract

Pulmonary sarcomatoid carcinoma; non-small cell lung cancer; EGFR mutation; MET amplification; crizotinib/gefitinib

30 Nov 2020Submitted to Clinical Case Reports

27 Feb 2021Submission Checks Completed

27 Feb 2021Assigned to Editor

21 Mar 2021Reviewer(s) Assigned

29 Apr 2021Review(s) Completed, Editorial Evaluation Pending

02 May 2021Editorial Decision: Revise Minor

05 May 20211st Revision Received

07 May 2021Submission Checks Completed

07 May 2021Assigned to Editor

07 May 2021Review(s) Completed, Editorial Evaluation Pending

18 May 2021Editorial Decision: Accept